Additionally, Western blot analysis of tumor tissues demonstrated that theasinensin A plus nimotuzumab resulted in a greater suppression of p-EGFR, p-ERK1/2, p-STAT3 and p-GSK3β. This evidence concerns the gene EGFR and neoplasm.